Markup of H.R. 4299, "Improving Regulatory Transparency for New Medical Therapies Act," H.R. 4709, "Ensuring Patient Access and Effective Drug Enforcement Act," and H.R. 4631, "Combating Autism Reauthorization Act," Subcommittee on Health (May 28, 2014)

Documents

Memorandum from Ranking Member Henry A. Waxman to Democratic Members of the Subcommittee on Health

Transcript

H.R. 4299, “Improving Regulatory Transparency for New Medical Therapies Act,” favorably forwarded by voice vote. 

H.R. 4709, “Ensuring Patient Access and Effective Drug Enforcement Act," favorably forwarded by voice vote.

H.R. 4631, “Combating Autism Reauthorization Act of 2014,” favorably forwarded, as amended, by voice vote. 

Amendment by Rep. Pitts, passed by voice vote.

Webcast

Key Documents: 

Memorandum from Ranking Member Henry A. Waxman, "Markup of H.R. 4299, H.R. 4709, and H.R. 4631" (May 27, 2014).

Transcript, Markup of "H.R. 4299, H.R. 4709, and H.R. 4631," Subcommittee on Health (May 28, 2014).

Bill Text of H.R. 4299, the "Improving Regulatory Transparency for New Medical Therapies Act" (March 26, 2014).

Bill Text of H.R. 4709, the "Ensuring Patient Access and Effective Drug Enforcement Act" (May 21, 2014).

Bill Text of H.R. 4631, the "Combating Autism Reauthorization Act of 2014" (May 9, 2014).

Pitts Amendment to H.R. 4631, "Combating Autism Reauthorization Act," Subcommittee on Health (May 28, 2014) .